Prolong Pharmaceuticals Competitors and Similar CompaniesClear all

Prolong Pharmaceuticals's competitors and similar companies include Jiangsu Hansoh Pharmaceutical Group, PLIVA and Biocon.

	Prolong Pharmaceuticals Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia.	Jiangsu Hansoh Pharmaceutical Group Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.	PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.	Biocon Biocon is a company that develops and manufactures biopharmaceutical products.
Founding Date	Founding Date 2005	Founding Date 1995	Founding Date 1921	Founding Date 1978
Type	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations South Plainfield, US HQ	Locations Lianyungang Shi, CN HQ	Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS	Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more
Employees	Employees 225% increase	Employees 8,989	Employees 1,685	Employees 16,5612% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥15b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹167.8b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods ¥1.1b (FY, 2025)	Cost of goods N/A	Cost of goods ₹56.9b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit ¥14b (FY, 2025)	Gross profit N/A	Gross profit ₹115.8b (FY, 2026)
Net income	Net income N/A	Net income ¥5.6b (FY, 2025)	Net income N/A	Net income ₹3.7b (FY, 2026)